CERN 63.01 Cerner Corp $CERN Hit a 52 week high of 63.96

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
CERN 63.01 Cerner Corp $CERN Hit a 52 week high of 63.96 Currently at 63.01 -0.87 -1.36% With a day low of 62.70 and a total volume of 1,695,800.

CERN Cerner Corp Recent Headline News

Cognizant CFO Karen McLaughlin Says Health Care, the Cloud Are Key to Growth
at The Street - Wed Nov 05, 12:10PM CST
Cognizant beat predictions on earnings, but now faces the challenge of becoming a major player in health care IT.
MCK: 199.32 (-3.34), WDAY: 94.56 (-0.43), CTSH: 53.62 (+0.98), HNT: 47.01 (-1.08), CERN: 63.01 (-0.87), CRM: 63.97 (+0.88)

Insider Trading Alert - CERN, MJN And AL Traded By Insiders
at The Street - Wed Nov 05, 11:25AM CST
Stocks with insider trader activity include CERN, MJN and AL
MJN: 98.39 (-0.45), AL: 37.60 (+0.09), CERN: 63.01 (-0.87)

Cerner and Livongo Announce Agreement to Help Health Care Providers and Patients Better Manage Diabetes
GlobeNewswire - Mon Nov 03, 7:38AM CST
Cerner Corp. (CERN) today announced a multi-year agreement with Livongo Health(TM) to connect diabetes screening data collected from "smart" consumer devices with Cerner health care clients. For people with diabetes, this can mean more effective self-management and a better use of time with their clinician. For care teams, this provides near real-time access to patient information, enabling quick interventions when a patient might be headed toward trouble.
CERN: 63.01 (-0.87)

Cerner to Present Comprehensive Preventive Care Solutions at Cerner Health Conference
GlobeNewswire - Fri Oct 31, 5:12PM CDT
Cerner Corporation (Nasdaq:CERN) today announced it will present its Preventive Care Advisor solution during the Cerner Health Conference (CHC) next week in Kansas City. The solution delivers real-time lists of eligible Medicare-approved preventive screenings, which can help improve care and overall patient wellness.
CERN: 63.01 (-0.87)

MedStar Health Signs Expanded Agreement With Cerner
GlobeNewswire - Thu Oct 30, 2:00PM CDT
MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C. region, and Cerner (Nasdaq:CERN) today announced an expanded partnership with a seven-year agreement that will streamline operations, help improve the quality of patient care and develop technologies that align with MedStar's vision to be the trusted leader in caring for people and advancing health.
CERN: 63.01 (-0.87)

Alere (ALR) Lags Q3 Earnings, Revenues; Outlook Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 12:40PM CDT
Alere Inc. (ALR) reported disappointing third-quarter 2014 results as both the top and the bottom line missed the Zacks Consensus Estimate by a wide margin
BIO: 110.60 (-0.50), ALR: 39.37 (-0.70), CERN: 63.01 (-0.87), ATHN: 123.82 (-1.94)

Truven Health Analytics and Cerner Partner to Make Micromedex Integrated CareNotes Available to Cerner EHR Clients
Business Wire - Wed Oct 29, 7:02AM CDT
Truven Health Analytics(TM) today announced an agreement with Cerner Corporation, a leading provider of health information and electronic health record (EHR) systems, to resell its Micromedex(R) CareNotes(R) product, a part of the Patient Connect Suite of patient and consumer education and engagement solutions. The evidence-based, health literacy standardized resources in CareNotes will be accessible directly from Cerner's EHR by clinicians in Acute Care and Ambulatory facilities and will include resources for the Emergency Department, Inpatient Discharge Instructions, General Health Summaries, Pre-care, Inpatient, Laboratory and Medication Education, among other tools and content, in multiple languages.
CERN: 63.01 (-0.87)

McKesson's Acquisition Powers Drug Revenue Higher
Todd Campbell, The Motley Fool - Motley Fool - Tue Oct 28, 6:14PM CDT
Source: McKesson. McKesson is one of the planet's biggest drug distributors. The company is responsible for delivering roughly one out of every three prescription drugs used in the United States daily and generates more than $138 billion in...
MCK: 199.32 (-3.34), CERN: 63.01 (-0.87)

Global Pharmacy Automation Systems Market Forecasts and Opportunities, 2019 - Analysis of the $4.1 Billion Industry
M2 - Tue Oct 28, 6:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zh84wk/pharmacy) has announced the addition of the "Pharmacy Automation Systems Market by product type & by End-user - Global Forecasts & Trends to 2019" report to their offering. The pharmacy automation market is expected to reach $4.5 billion by 2019 from $3.1 billion in 2014 The global pharmacy automation systems market has witnessed considerable growth over the past few years and is further expected to grow In this report the market is segmented by product, end user, and by geography. On the basis of product, the market includes automated medication dispensing systems, automated packaging and labeling systems, automated medication compounding systems, storage and retrieval systems, table-top counters, and other systems. Whereas, on the basis of end users, the market includes the inpatient pharmacy units, outpatient pharmacy units, retail pharmacies, and pharmacy benefit management organizations and other mail-order setting. The inpatient pharmacy automation market is further classified as acute care setting and long-term care setting, while the outpatient pharmacy automation market is segmented into fast-track clinics and hospital pharmacies. Factors such as the necessity of cost containment, reduction of medication errors, and the need to increase the efficiency of work within the pharmacies are the major drivers for the pharmacy automation systems market. However, stringent regulatory guidelines which delay product launches, high costs of implementation of automation systems, and restricted budgets of healthcare that lower investments in the automated systems by small companies are some of the key factors restraining the growth of the global market. However, the increasing awareness regarding the benefits of the pharmacy automation systems in the developing countries offer new growth opportunities to the market players. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Pharmacy Automation Systems Market, By Product 5 Global Pharmacy Automation Systems Market, By End-Users 6 Global Pharmacy Automation Systems Market, By Geography 7 Competitive Landscape 8 Company Profiles - Baxter International Inc. - Carefusion Corporation - Cerner Corporation - Kirby Lester - Mckesson Corporation - Omnicell, Inc. - Parata Systems Llc - Scriptpro Llc - Swisslog Holding Ag - Talyst, Inc. For more information visit http://www.researchandmarkets.com/research/zh84wk/pharmacy
BAX: 70.61 (-0.99), OMCL: 31.89 (-0.28), CERN: 63.01 (-0.87)

Brother Mobile Solutions to Showcase its Cerner Certified Patient ID Printers at the Cerner Health Conference (CHC) 2014
Business Wire - Tue Oct 28, 6:02AM CDT
Brother Mobile Solutions, Inc. (BMS) a wholly-owned subsidiary of Brother International Corporation and premier provider of mobile and desktop thermal printing products, announces that it will showcase its Cerner-certified TrustSense(TM) healthcare patient ID printing solution at the Cerner Health Conference 2014, November 2-5 in Kansas City, Missouri. Developed in partnership with PDC Healthcare, the mobile solution provides on-demand wristband and label printing virtually anywhere in the hospital.
CERN: 63.01 (-0.87)

How Obamacare Could Save Taxpayers $17 Billion
Todd Campbell, The Motley Fool - Motley Fool - Sun Oct 26, 12:31PM CDT
Source: 401kcalculator.org via Fickr. Obamacare has its work cut out for it. Healthcare spending in the U.S. totals about $3 trillion annually, and growing expenses tied to caring for ageing baby boomers has industry watchers expecting that...
CERN: 63.01 (-0.87)

Cerner (CERN) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Oct 24, 9:17PM CDT
The following Cerner (CERN) conference call took place on October 23, 2014, 04:30 PM ET. This is a transcript of that earnings call:
CERN: 63.01 (-0.87)

Cerner Set to Possibly Pullback After Yesterday's Rally of 2.38%
Comtex SmarTrend(R) - Fri Oct 24, 5:29PM CDT
Cerner (NASDAQ:CERN) traded in a range yesterday that spanned from a low of $59.16 to a high of $61.17. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $60.28 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CERN: 63.01 (-0.87)

After Yesterday's Rally of 2.38% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Oct 24, 5:29PM CDT
Cerner (NASDAQ:CERN) traded in a range yesterday that spanned from a low of $59.16 to a high of $61.17. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $60.28 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CERN: 63.01 (-0.87)

Stocks Cling To Decent Gains; Alibaba Nears High
at Investor's Business Daily - Fri Oct 24, 12:25PM CDT
Stocks came off session highs midday Friday as the major indexes looked to finish the week with big gains. Blue chips led, with the Dow Jones industrial average up 0.4%. Twenty-five of the 30 Dow stocks were higher at midday, led by Proctor & Gamble...
MMM: 156.55 (+0.50), PFE: 29.92 (-0.12), PG: 89.13 (+0.23), MSFT: 48.68 (-0.02), AAPL: 109.01 (+0.31), CERN: 63.01 (-0.87), BABA: 114.56 (+2.99)

Cerner Sees In-Line Q3 Earnings but Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:50AM CDT
For the fourth quarter of 2014, Cerner Corporation (CERN) anticipates revenues between $880 and $915 million
QSII: 14.56 (-0.34), MDRX: 11.54 (-2.01), CERN: 63.01 (-0.87), ATHN: 123.82 (-1.94)

CERNER
at Investor's Business Daily - Thu Oct 23, 5:56PM CDT
CERNER (CERN), a health-info tech firm, said its Q3 EPS rose 20% to 42 cents, in line, and sales rose 15.4% to $840.1 mil, missing. Shares fell 2.1% to 58.46.
CERN: 63.01 (-0.87)

Cerner meets 3Q profit forecasts
Automated Insights - Thu Oct 23, 3:21PM CDT
KANSAS CITY, Mo. (AP) _ Cerner Corp. (CERN) on Thursday reported third-quarter profit of $129 million.
CERN: 63.01 (-0.87)

Cerner Reports Third Quarter 2014 Results
GlobeNewswire - Thu Oct 23, 3:02PM CDT
Cerner Corporation (Nasdaq:CERN) today announced results for the 2014 third quarter that ended September 27, 2014, delivering strong levels of bookings, revenue, earnings and cash flow.
CERN: 63.01 (-0.87)

Nascent Rally Gains Traction; Caterpillar, 3M Boost Dow
at Investor's Business Daily - Thu Oct 23, 1:58PM CDT
Major averages showed broad gains and were near session highs with a little more than one hour remaining in Wednesday's session. The Nasdaq jumped 2.1% and the S&P 500 and Dow Jones industrial average gained 1.8% each. The Dow was helped by strong...
AMZN: 299.86 (+3.22), LCI: 50.17 (-0.82), MMM: 156.55 (+0.50), AAP: 141.85 (-3.71), ORLY: 179.00 (-0.61), CAT: 101.76 (+0.85), EPAM: 46.95 (-0.97), CERN: 63.01 (-0.87)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vanda Pharmaceuticals Steps Into September Investor Talks

Updated Category News Views 0

Vanda Pharmaceuticals Heads Into Key Investor Spotlights In the relentless quest for market edge, Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is setting the stage for what could be some telling moments in September 2026. Investors with a keen interest in the pharmaceutical realm should seat themselves upfront as Vanda takes the floor in a series of pivotal conferences. Each...

Continue Reading
Texas Institute Leads Trailblazing Arrhythmia Study

Updated Category News Views 2

Breaking New Ground in Heart Rhythm Treatment Well, here's a twist that even the stock market folks might envy—pioneering innovation in healthcare. This time, it’s not about tech stocks or a bull market, but about real human lives. The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center in Austin has jumped to the forefront by participating in a...

Continue Reading
GenesisFX Rolls Out Live Leaderboards, Boosts Social Trading

Updated Category News Views 3

Traders buckle up! GenesisFX Markets just kicked open a new chapter in forex and CFD trading with their Live Leaderboards and beefed-up social trading tools. What's the commotion about? Well, that's your hook. These leaderboards are the newest addition to their ecosystem, paired with some serious social trading muscle. As Arkadiusz Bujalski, the Head of Ops and System...

Continue Reading
TCOM Secures $600M Deal to Boost NATO's Defense

Updated Category News Views 1

TCOM's Pivotal $600 Million Defense Contract How often do you hear about a deal north of $600 million that practically revamps a company's strategic future? That's precisely what's hitting the books at TCOM right now. They've scored a heavy-hitting Foreign Military Sales (FMS) contract to fortify NATO's eastern front with Poland. I'll tell you this—it’s one of the...

Continue Reading
Qingdao-Yerevan Collaboration: New Strategic Heights

Updated Category News Views 2

Qingdao and Yerevan: More Than Just a Port of Call Who would have thought? An Armenian ambassador talking shop in a Chinese port city isn't your everyday headline, but let me tell you, it's big news if you're watching global growth. Armenian Ambassador Vahe Gevorgyan's recent spiel in Qingdao might not turn heads on Wall Street, but there's more under the hood than meets...

Continue Reading
Crunch Fitness Organizes Major 9/11 Tribute Event

Updated Category News Views 0

A Climb for Remembrance In the realm of tributes that hit home, Fitness Ventures might have just nailed one. On this 25th anniversary of September 11, they're pulling no punches by bringing the gritty spirit of NYC right into the heart of 106 Crunch Fitness locations across America. You want to talk about a tribute that resonates, this is it—a Nationwide 9/11...

Continue Reading
ASUS Harnesses AI Power with ProArt RTX Spark PCs

Updated Category News Views 3

When ASUS throws its hat in the ring, you know it's going for the knockout. At IFA 2026, they're swinging for the fences with their new ProArt lineup—powered by NVIDIA RTX Spark. We're talking serious AI muscle here, up to 1 petaflop worth! What Makes This Lineup a Game Changer? The ProArt series, comprising of the P16 and P14 laptops, alongside the GR1X mini PC, is a...

Continue Reading
NEXA Unlimited: Disrupting Mortgage Broker Earnings

Updated Category News Views 7

What Exactly Is NEXA Unlimited? In a game-changer twist, NEXA Lending has launched something that could dramatically shuffle the current mortgage broker model deck. Dubbed NEXA Unlimited, this new model promises no less than 100% revenue access to its loan officers. We're talking zero fees—flat, funding, closing—none of ‘em. This isn't a small tweak or a cosmetic...

Continue Reading
Mito Health Achieves Milestone: A Million Lab Tests

Updated Category News Views 0

A Million Reasons to Take Note: Mito Health Expands If you've been snoozing on this, it's time to wake up. Mito Health just blew past a major milestone, hitting over one million lab tests since they set up shop in the diagnostics marketplace. That's no small potatoes for a company that's still fresh-faced since its 2023 debut in San Francisco. Revolutionizing Preventive...

Continue Reading
OCI Energy and Arava Power Ignite SunRoper Solar Project

Updated Category News Views 5

Bridging Houston's Energy Gap with New Solar Power There's a new player in town aiming to meet the growing electricity demand in the Houston area. On September 1, 2026, OCI Energy and Arava Power, along with their project partners, broke ground on the SunRoper Solar project in Wharton County, Texas. This isn't just any solar venture; it's a hefty 347 MWdc facility that's...

Continue Reading

Top 5 Most Recently Viewed Articles

Tempus AI: Important Legal Reminder for Investors

Updated Category News Views 112

Understanding Tempus AI's Legal Situation Tempus AI, Inc. has recently found itself at the center of a legal storm, and it's crucial for investors to be aware of the developments that could impact their interests. Bragar Eagel & Squire, P.C., a well-respected law firm, has been actively engaging with shareholders who have experienced losses. How Tempus AI Investors Can...

Continue Reading
Projected Growth of the Fatty Amines Market to $4.97 Billion

Updated Category News Views 214

Overview of the Fatty Amines Market The fatty amines market is poised for significant growth, with projections indicating an increase from USD 3.60 billion in 2025 to USD 4.97 billion by 2030. This growth, reflecting a compound annual growth rate (CAGR) of 6.7%, is attributed to heightened demand across various sectors. The Influence of Eco-friendly Practices As...

Continue Reading
NIP Group Finalizes Major Crypto Mining Assets Acquisition

Updated Category News Views 130

NIP Group Inc. Completes New Acquisition in Crypto Mining NIP Group Inc. (NASDAQ: NIPG), a trailblazer in the digital entertainment industry, has successfully finalized a significant acquisition of on-rack crypto mining machinery. This strategic move is designed to enhance their operational capacity, enabling them to accelerate growth in the crypto asset sector. Details...

Continue Reading
Understanding the Altimmune Class Action Lawsuit for Investors

Updated Category News Views 189

The Class Action Lawsuit Against Altimmune Investors affected by the recent events surrounding Altimmune (NASDAQ: ALT) have an opportunity to participate in an important class action lawsuit. The lawsuit was launched by Bragar Eagel & Squire, P.C., a renowned law firm specializing in stockholder rights. It pertains to all individuals who acquired securities of Altimmune...

Continue Reading
Koryx Copper's Promising Drill Insights Reveal Project Growth

Updated Category News Views 275

Exciting Drill Results from Koryx Copper's Haib Project Koryx Copper Inc. (TSX-V: KRY) has recently unveiled assay results that are making waves in the mining community. These results are derived from an active and promising drill program at the Haib Copper Project. This ongoing effort is part of Koryx’s strategy for exploration and project development. The current...

Continue Reading